🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/01/2018 | 88,21 | 88,45 | 86,29 | 88,04 | -0,18% | 2,45% | 281.807 |
| 05/01/2018 | 88,65 | 89,61 | 87,90 | 88,20 | -0,50% | 1,93% | 402.353 |
| 04/01/2018 | 88,00 | 89,49 | 88,00 | 88,64 | +0,45% | 1,69% | 188.353 |
| 03/01/2018 | 86,71 | 89,17 | 86,47 | 88,25 | +2,04% | 3,12% | 680.153 |
| 02/01/2018 | 85,91 | 86,99 | 85,31 | 86,48 | +1,24% | 1,96% | 235.641 |
| 29/12/2017 | 86,52 | 87,01 | 85,13 | 85,42 | -1,25% | 2,18% | 301.524 |
| 28/12/2017 | 86,51 | 86,85 | 85,64 | 86,50 | +0,19% | 1,40% | 181.460 |
| 27/12/2017 | 85,54 | 86,63 | 85,10 | 86,34 | +1,47% | 1,78% | 256.320 |
| 26/12/2017 | 84,52 | 85,83 | 84,12 | 85,09 | +0,70% | 2,02% | 184.666 |
| 22/12/2017 | 84,88 | 85,13 | 84,24 | 84,50 | -0,02% | 1,04% | 191.078 |
| 21/12/2017 | 84,85 | 85,25 | 84,29 | 84,52 | -0,58% | 1,12% | 149.239 |
| 20/12/2017 | 86,78 | 86,92 | 84,73 | 85,01 | -1,37% | 2,53% | 197.650 |
| 19/12/2017 | 85,58 | 86,87 | 85,09 | 86,19 | +0,76% | 2,08% | 393.056 |
| 18/12/2017 | 85,23 | 86,17 | 84,73 | 85,54 | +0,92% | 1,69% | 241.252 |
| 15/12/2017 | 84,50 | 85,15 | 83,25 | 84,76 | -0,13% | 2,24% | 623.727 |
| 14/12/2017 | 85,64 | 86,69 | 84,84 | 84,87 | -0,98% | 2,16% | 236.923 |
| 13/12/2017 | 84,61 | 86,54 | 84,61 | 85,70 | +1,16% | 2,29% | 288.540 |
| 12/12/2017 | 84,60 | 85,31 | 84,30 | 84,72 | +0,55% | 1,19% | 307.616 |
| 11/12/2017 | 84,17 | 85,08 | 83,52 | 84,25 | +0,27% | 1,86% | 270.907 |
| 08/12/2017 | 82,33 | 84,61 | 81,98 | 84,02 | +2,32% | 3,19% | 347.050 |
| 07/12/2017 | 80,87 | 82,78 | 80,04 | 82,11 | +1,61% | 3,38% | 329.577 |
| 06/12/2017 | 79,79 | 81,10 | 79,64 | 80,82 | +0,93% | 1,83% | 179.055 |
| 05/12/2017 | 80,46 | 81,47 | 79,86 | 80,07 | -0,73% | 2,00% | 228.107 |
| 04/12/2017 | 82,10 | 82,28 | 80,64 | 80,66 | -0,97% | 2,01% | 281.166 |
| 01/12/2017 | 81,98 | 82,13 | 78,91 | 81,45 | -0,97% | 3,93% | 274.113 |
| 30/11/2017 | 81,93 | 83,09 | 81,62 | 82,25 | +0,76% | 1,80% | 375.262 |
| 29/11/2017 | 81,72 | 82,61 | 81,04 | 81,63 | +0,18% | 1,92% | 246.702 |
| 28/11/2017 | 81,51 | 82,12 | 80,21 | 81,48 | +0,29% | 2,34% | 354.423 |
| 27/11/2017 | 83,33 | 83,37 | 81,10 | 81,25 | -2,60% | 2,73% | 277.479 |
| 24/11/2017 | 82,99 | 83,62 | 82,98 | 83,41 | +0,49% | 0,78% | 107.561 |